Pharmacogenomic Variation and Chemotherapy-Related Toxicity Profiles in Pediatric Patients With Cancer in Tanzania: A Cross-Sectional Study

    July 2026 in “ Frontiers in Pharmacology ”
    Deogratias M. Katabalo, Baraka Fundo, Winfrida V. Minja … Benson R. Kidenya
    Studysummary This study assessed pharmacogenomic variants and chemotherapy-related toxicity profiles in Tanzanian children with cancer, reporting notable genetic diversity that may influence toxicity but did not evaluate genotype-toxicity associations.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on frontiersin.org →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Drug Utilization Pattern and Adverse Drug Reactions of Chemotherapy in Pediatric Patients at Muhimbili National Hospital, Tanzania F1000Research · 2022